biotech market access

Global expansion has become a strategic priority for US biotechnology companies seeking new growth opportunities beyond domestic markets. As the industry matures and innovation pipelines expand, firms are increasingly targeting international regulatory approvals, cross-border partnerships, and diversified commercialization channels. Expanding globally allows biotech companies to reach larger patient populations, access new capital sources, and strengthen … Read more